Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation [6]

Gastroenterology

Volumn 124, Issue 2, 2003, Pages 586-587

  Van Bömmel, Florian ^a   Schernick, Andrea ^a   Hopf, Uwe ^a   Berg, Thomas ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; FAMCICLOVIR; INTERFERON; LAMIVUDINE; PEGINTERFERON; TENOFOVIR DISOPROXIL; UNCLASSIFIED DRUG; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL ACTIVITY; CASE REPORT; DRUG EFFICACY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LETTER; MALE; PRIORITY JOURNAL; VIRUS LOAD; VIRUS REACTIVATION;

EID: 0037308267     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2003.1240586b     Document Type: Letter

References (9)

1. Bonacini M, Kurz A, Locarnini S, Ayres A, Gibbs C. Fulminant hepatitis B due to a lamivudine-resistant mutant of HBV in a patient coinfected with HIV. Gastroenterology 2002;122:244-245.
2. Ying C, De Clercq E, Nicholson W, Furman P, Neyts J. Inhibition of the replication of the DNA polymerase M550V mutation variant of human hepatitis B virus by adefovir, tenofovir, L-FMAU, DADP, penciclovir and lobucavir. J Viral Hepat 2000;7:161-165.
3. Cihlar T, Birkus G, Greenwalt DE, Hitchcock MJM. Tenofovir exhibits low cytotoxicity in various human cell types: comparison with other nucleoside reverse transcriptase inhibitors. Antiviral Res 2002;54:37-45.
4. James JS. Tenofovir approved: broad indication. AIDS Treat News 2001;26:2-3.
5. van Bömmel F, Wünsche T, Schürmann T, Berg T. Tenofovir treatment in patients with lamivudine-resistant hepatitis B mutants. Hepatology 2002;35 (in press).
6. Benhamou Y, Bochst M, Tubiana R, Thibault V, Suffisseau L, Sullivan M, Rooney J, Brosgart C, Bricaire F, Katlama C. Tenofovir disoproxil fumarate (TDF) suppresses lamivudine-resistant HBV replication in patients co-infected with HIV/HBV. J Hepatol 2002;36:138 (abstr).
7. Stuyver LJ, Locarnini SA, Lok A, Richman DD, Carman WF, Dienstag J, Schinazi R. Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region. Hepatology 2001;33:751-757.
8. Lok AS, Heathcote EJ, Hoofnagel JH. Management of Hepatitis B 2000 - Summary of a workshop. Gastroenterology 2001;120:1828-1853.
9. Peters M, Hann HW, Martin P, Heathcote E, Buggisch P, Moorat AE, Sullivan M, Kleber K, Ebrahim R, Xiong S, Brosgart C. Adefovir Dipivoxil (ADV) alone and in combination with lamivudine (LAM) suppresses lam-resistant hepatitis B virus (HBV) replication: 16 week interim analysis. J Hepatol 2002;36:6 (abstr).